Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen

TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...

November 20, 2022, 6:30 pm

Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen

TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...

November 20, 2022, 6:30 pm

Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen

TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...

November 20, 2022, 6:30 pm

Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen

TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...

November 20, 2022, 6:30 pm

Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen

TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker...

November 20, 2022, 6:30 pm

2 unstoppable growth stocks to buy now and hold forever

A topsy-turvy stock market isn't going to knock these growth stocks off of their upward-sloping paths forward....

November 20, 2022, 6:51 am

Compass pathways uses psychoactive treatment for depression — ceo explains

Biotech company Compass Pathways is up more than 100 since its IPO debut. The company aims to treat depression through psychedelic mushrooms and is ba...

November 19, 2022, 8:19 am

Forex-u.s. dollar gains ground as investors focus on future fed path

(Updates prices, adds commentary) * Euro hits three-month high against the dollar * Fed’s Waller: CPI last week was ‘just one data point’ * Fed�...

November 19, 2022, 5:01 am

Uipath ceo daniel dines on its first earnings as a public company

Uipath CEO Daniel Dines joins "TechCheck" to discuss the company's first round of earnings after going ...

November 19, 2022, 4:41 am

Fda approves biogen alzheimer's treatment

CNBC's Meg Tirrell reports on FDA approval of Biogen's Alzheimer's treatment under an 'accelerated approval pathway.'...

November 19, 2022, 2:21 am

Crude oil is ‘clearly pricing in slower economies': analyst

Bob Iaccino, path Trading Partners Co-Founder and Chief Market Strategist and The Stock Think Tank Co-P...

November 18, 2022, 4:06 pm

Molson to end its truss cbd usa joint venture with hexo

Molson Coors Beverage Co. TAP, +0.51% said it's exiting its roughly two-year-old Truss CBD USA beverage joint venture with Hexo Corp. HEXO, -1.29% at ...

November 18, 2022, 2:51 pm

The real reason jd stock is climbing today

Shares of Chinese e-commerce giant JD.com (NASDAQ: JD ) are climbing 3% after the company reported mixed third-quarter results today. Today's gains co...

November 18, 2022, 9:57 am

Gold price forecast: xauusd sees an easy path toward $1,750 and $1,745 – confluence detector

Gold price is consolidating losses above $1,750 amid a firmer US Dollar and Treasury yields. Hawkish Federal Reserve commentary saved the day for the ...

November 18, 2022, 4:31 am

1 growth stock set to win big in 2023

Joining the Layoff Club means Uipath can amp up the bot revolution next year....

November 17, 2022, 7:40 am

Eur/usd: bank of america lays out the path for an inverted head-and-shoulders

Bank of America Global Research discusses EUR/USD technical outlook and looks for hints of and H&S top.

"A technical bottom pattern would go ...

November 16, 2022, 7:02 pm

What's going on with costco stock today? - costco wholesale (nasdaq:cost)

Costco Wholesale Corp (NASDAQ: COST) shares are trading lower Wednesday in sympathy with Target Corp (NYSE: TGT), which fell after the company reporte...

November 16, 2022, 8:43 am

Usd/jpy technical analysis: attempts to stop downward path

For the second day in a row, the price of the usd/jpy currency pair is trying to rebound higher. It is stable above the important psychological resis ...

November 16, 2022, 6:01 am

The path for bitcoin to be true digital cash

The original intent for bitcoin involved regular usage — and that needs to be encouraged in order to see full adoption. Read Full Story The post The...

November 16, 2022, 2:31 am

Gold price forecast: xauusd advances steadily around $1770 on a cool us ppi report

US Treasury bond yields plunged on Fed policymakers, paving the path for slower rate hikes. XAUUSD prep...

November 16, 2022, 12:01 am